MLICM
TBIO

Metropolitan Life Insurance Company (MetLife)’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,791
Closed -$573K – 2861
2021
Q2 		$573K Buy
20,791
+1,324
+7% +$26K 0.01% 1437
2021
Q1 		$321K Sell
19,467
-887
-4% -$20.2K ﹤0.01% 1706
2020
Q4 		$375K Hold
20,354
– – 0.01% 1554
2020
Q3 		$277K Buy
20,354
+4,617
+29% +$71.2K ﹤0.01% 1585
2020
Q2 		$282K Buy
15,737
+4,065
+35% +$61.3K 0.01% 1586
2020
Q1 		$116K Buy
11,672
+1,668
+17% +$13.7K ﹤0.01% 1936
2019
Q4 		$81.4K Sell
10,004
-1,701
-15% -$15.7K ﹤0.01% 2434
2019
Q3 		$116K Hold
11,705
– – ﹤0.01% 2222
2019
Q2 		$148K Hold
11,705
– – ﹤0.01% 2093
2019
Q1 		$119K Buy
+11,705
New +$89.7K ﹤0.01% 2216

Metropolitan Life Insurance Company (MetLife)'s TBIO Position: Q3 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 20,791 shares — an estimated $573K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TBIO in Q1 2019 and held it in 10 quarters. The position peaked at $573K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 20,791 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $573K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Translate Bio, Inc. Common Stock position peaked at $573K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.